NCT07205393

Brief Summary

Cardiac rehabilitation is a crucial component of postoperative recovery for patients who have received valve replacement surgery. Aim: This study aimed to evaluate the effectiveness of phase one cardiac rehabilitation in improving cardiovascular function, pulmonary capacity, functional ability, and quality of life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 23, 2025

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2025

Completed
Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

September 23, 2025

Last Update Submit

September 30, 2025

Conditions

Keywords

Cardiac rehabilitationValve replacementSpirometry measures

Outcome Measures

Primary Outcomes (4)

  • Oxygen saturation.

    Oxygen saturation: (2700 Branshaj, Denemark).

    5 to 6 days

  • FVC

    Forced vital capacity (FVC)

    5 to 6 days

  • FEV1

    forced expiratory volume in the first second (FEV1)

    5 to 6 days

  • FEV1/FVC.

    The ratio of FEV1 on FVC.

    5 to 6 days

Secondary Outcomes (1)

  • The 6-Minute Walk Test (6MWT)

    5 to 6 days

Study Arms (2)

Cardiac rehabilitation

OTHER

The intervention group underwent the cardiac rehabilitation program from the first day following surgery regarding the clinical guideline for rehabilitation in patients with cardiovascular disease.17 This rehabilitation exercise program formed of breathing exercises, lower and upper extremity exercises in bed, sitting on the edge of the bed, standing at the bedside, and walking around the bed and for 100 m in the ward. The patient performed three sessions per day, with approximately 20 minutes each time. After the rehabilitation exercise, patients continued with gait practice for up to 500 m and carried out endurance training by using a stationary bike in the rehabilitation center of the hospital. The sessions continued until they were discharged from the hospital (approximately 5 to 6 days post operative). The intensity of physical activity was limited by clinical conditions and activity tolerance, and monitored and assessed by physical therapists, plus routine clinical care.

Other: Cardiac rehabilitationOther: Routine clinic care

Control group

OTHER

The control group did not joined any rehabilitation program and only received routine clinical care during the duration of the hospital stay (approximately 5 to 6 days post operative). Data collection The investigators assessed all patients on the day before surgery (baseline assessment) and the day of hospital discharge.

Other: Routine clinic care

Interventions

The intervention group underwent the cardiac rehabilitation program from the first day following surgery regarding the clinical guideline for rehabilitation in patients with cardiovascular disease.17 This rehabilitation exercise program formed of breathing exercises, lower and upper extremity exercises in bed, sitting on the edge of the bed, standing at the bedside, and walking around the bed and for 100 m in the ward. The patient performed three sessions per day, with approximately 20 minutes each time. After the rehabilitation exercise, patients continued with gait practice for up to 500 m and carried out endurance training by using a stationary bike in the rehabilitation center of the hospital. The essions continued until they were discharged from the hospital (approximately 5 to 6 days post operative). The intensity of physical activity was limited by clinical conditions and activity tolerance, and monitored and assessed by physical therapists. Plus routine clinical care

Cardiac rehabilitation

The control group did not joined any rehabilitation program and only received routine clinical care during the duration of the hospital stay (approximately 5 to 6 days post operative).

Cardiac rehabilitationControl group

Eligibility Criteria

Age40 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • and to be hemodynamically stable to qualify for a structured rehabilitation program.
  • Being able to understand and complete measurements.
  • And provide informed written consent.

You may not qualify if:

  • Patient with ischemic heart disease before surgery.
  • Those with severe musculoskeletal system disorders.
  • Patients who had persistent or paroxysmal atrial fibrillation.
  • Individuals with severe heart failure.
  • uncontrolled arrhythmias.
  • Comorbidity complicating physical activity or other contraindications to phase one cardiac rehabilitation and Patients who underwent an emergency surgical intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South valley university

Qina, Egypt

RECRUITING

MeSH Terms

Interventions

Cardiac Rehabilitation

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

Shymaa Yussuf Abo-Zaid, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 23, 2025

First Posted

October 3, 2025

Study Start

January 1, 2025

Primary Completion

October 1, 2025

Study Completion

October 20, 2025

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

I will not share it outside the primary research group.

Locations